InvestorsHub Logo
Post# of 253152
Next 10
Followers 97
Posts 92809
Boards Moderated 4
Alias Born 10/29/2007

Re: None

Thursday, 11/08/2012 9:44:41 AM

Thursday, November 08, 2012 9:44:41 AM

Post# of 253152
DUSA Pharmaceuticals (DUSA) +37.7% premarket after agreeing to be acquired by India's Sun Pharma for $8/share, giving the deal a total cash value of ~$230M. The price represents a 38% premium to DUSA's closing price yesterday. Dermatology company DUSA develops and markets the Levulan photodynamic therapy platform for the face and scalp
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.